Effects of adrenergic neurotransmitters on the uterus.
D000818:Animals; D002118:Calcium / Q000378:metabolism; D002395:Catecholamines / Q000494:pharmacology*; D002463:Cell Membrane Permeability / Q000187:drug effects; D004558:Electric Stimulation; D004837:Epinephrine / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D008564:Membrane Potentials / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D011188:Potassium / Q000378:metabolism; D011247:Pregnancy; D011374:Progesterone / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic; D012964:Sodium / Q000378:metabolism; D013564:Sympathetic Nervous System; D014599:Uterus / Q000166:cytology / Q000187:drug effects* / Q000294:innervation / Q000378:metabolism
D002395:Catecholamines; D004967:Estrogens; D011941:Receptors, Adrenergic; D011374:Progesterone; D012964:Sodium; D011188:Potassium; D002118:Calcium; D009638:Norepinephrine; D004837:Epinephrine